EyePoint Pharmaceuticals Inc (EYPT)
16.72
+0.56
(+3.50%)
USD |
NASDAQ |
Apr 26, 16:00
16.72
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Gross Profit (Quarterly): 13.03M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.03M |
September 30, 2023 | 14.00M |
June 30, 2023 | 7.313M |
March 31, 2023 | 7.043M |
December 31, 2022 | 7.123M |
September 30, 2022 | 8.607M |
June 30, 2022 | 9.831M |
March 31, 2022 | 7.517M |
December 31, 2021 | 8.511M |
September 30, 2021 | 7.234M |
June 30, 2021 | 7.084M |
March 31, 2021 | 5.933M |
December 31, 2020 | 4.67M |
September 30, 2020 | 13.81M |
June 30, 2020 | 3.62M |
March 31, 2020 | 6.509M |
December 31, 2019 | 7.309M |
September 30, 2019 | 2.182M |
June 30, 2019 | 6.504M |
March 31, 2019 | 1.682M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 1.659M |
June 30, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
2.182M
Minimum
Sep 2019
14.00M
Maximum
Sep 2023
7.781M
Average
7.234M
Median
Sep 2021
Gross Profit (Quarterly) Benchmarks
INVO Bioscience Inc | 0.495M |
Bio-Path Holdings Inc | -- |
Ocular Therapeutix Inc | 13.42M |
Aileron Therapeutics Inc | -- |
Apellis Pharmaceuticals Inc | 126.46M |